CymitQuimica logo
Ras

Ras

Las proteínas Ras son pequeñas GTPasas que actúan como interruptores moleculares en la vía de señalización MAPK, controlando el crecimiento, la diferenciación y la supervivencia celular. Ras activado inicia una cascada de señalización que incluye Raf, MEK y ERK, lo que lleva a diversas respuestas celulares. Las mutaciones en los genes Ras son comunes en el cáncer, lo que convierte a Ras en un enfoque importante de la investigación oncológica. En CymitQuimica, ofrecemos una gama de moduladores de Ras para apoyar su investigación en biología del cáncer, transducción de señales y desarrollo terapéutico.

Se han encontrado 167 productos para "Ras".

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • INCB159020

    CAS:
    INCB159020 is an orally active inhibitor of KRAS G12D, exhibiting a KRAS G12D SPR value of 2.2 nM. It demonstrates anti-tumor activity.
    Fórmula:C37H35ClFN7O2
    Forma y color:Solid
    Peso molecular:664.171

    Ref: TM-T204240

    100mg
    A consultar
    25mg
    4.311,00€
    50mg
    6.139,00€
  • XMU-MP-9

    CAS:
    XMU-MP-9, a bifunctional compound, targets the C2 domain of Nedd4-1 and the allosteric site of K-Ras. It enhances the interaction and induces conformational changes within the Nedd4-1/K-Ras complex. Furthermore, XMU-MP-9 facilitates the ubiquitination and degradation of various K-Ras mutants and inhibits the proliferation of cells with these mutants. This compound is useful in cancer research.
    Fórmula:C19H13ClFN3OS
    Forma y color:Solid
    Peso molecular:385.84

    Ref: TM-T200189

    25mg
    1.369,00€
    50mg
    1.783,00€
    100mg
    2.250,00€
  • AH001

    CAS:
    AH001 is an orally active compound that binds to a concealed pocket near GDP within RhoA, exhibiting a binding affinity of 73.16 nM. By interacting with GDP, AH001 stabilizes the interaction between RhoA and its endogenous inhibitor, RhoGDIα. This compound reduces nuclear translocation of downstream MRTFA and downregulates fibrosis/hypertrophy-related proteins. AH001 alleviates myocardial remodeling in various heart failure animal models and 3D cardiac tissue models. Its cardioprotective effects are mediated through the RhoA-RhoGDIα axis, effectively inhibiting downstream RhoA activation signals.
    Fórmula:C10H14O2
    Peso molecular:166.22

    Ref: TM-T210940

    25mg
    1.998,00€
    50mg
    2.412,00€
    100mg
    2.880,00€
  • SOS2 ligand 1

    CAS:
    SOS2 ligand 1 (compound 2) is a selective ligand for son of sevenless 2 (SOS2), exhibiting a KD value of 4.6 µM.
    Fórmula:C19H21N5O
    Forma y color:Solid
    Peso molecular:335.403

    Ref: TM-T204872

    10mg
    A consultar
    50mg
    A consultar
  • pan-KRAS-IN-17

    CAS:
    pan-KRAS-IN-17 (Example 34) is an inhibitor that targets multiple forms of the KRAS protein.
    Fórmula:C34H33F3N5O8P
    Forma y color:Solid
    Peso molecular:727.623

    Ref: TM-T205570

    10mg
    A consultar
    50mg
    A consultar
  • BMS-214662

    CAS:
    BMS-214662 is a selective farnesyl transferase inhibitor with anti-tumor activity, used in research on pancreatic cancer, head and neck cancer, and lung cancer.
    Fórmula:C25H23N5O2S2
    Pureza:99.58% - 99.58%
    Forma y color:Yellow Viscous
    Peso molecular:489.61

    Ref: TM-T10567

    25mg
    2.043,00€
    50mg
    2.682,00€
    100mg
    3.600,00€
  • KRas G12C inhibitor 2

    CAS:
    KRas G12C inhibitor 2 is a compound that inhibits KRas G12C.
    Fórmula:C32H37N7O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:567.68

    Ref: TM-T11777

    25mg
    1.369,00€
    50mg
    1.783,00€
    100mg
    2.250,00€